Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Jakavi approved in Europe

Aug. 29, 2012

MORAb-004 enters new phase II trial

Aug. 28, 2012

Novel candidate cancer drugs presented

Aug. 28, 2012

French team designs novel antiangiogenic agents

Aug. 28, 2012

Seattle Genetics kicks off new study in renal cell carcinoma

Aug. 27, 2012

New everolimus formulation approved in Japan

Aug. 27, 2012

Novartis reports new mTOR/PI3K inhibitors

Aug. 27, 2012

New inhibitors of V600E-mutant B-raf presented

Aug. 27, 2012

PCI Biotech selects next indication for Amphinex

Aug. 24, 2012

Research at U.S. university yields new MAT 2 inhibitors

Aug. 24, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...